The FDA supports the study design of the so-called ATHENA trial and its primary and secondary endpoints. Tiprelestat has already been granted orphan designation in PAH in the U.S. and in Europe.
The FDA supports the study design of the so-called ATHENA trial and its primary and secondary endpoints. Tiprelestat has already been granted orphan designation in PAH in the U.S. and in Europe. The ...
Menounos welcomed her daughter Athena with husband Keven Undergaro in June 2023 Maria Menounos/Instagram Maria Menounos is remembering a time when one of her friends shamed her for having her ...
The FDA supports the study design of the so-called ATHENA trial and its primary and secondary endpoints. Tiprelestat has already been granted orphan designation in PAH in the U.S. and in Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback